期刊文献+

外周血白细胞计数及其分类与血液透析患者心血管事件发生及一年病死率相关 被引量:3

Decreased lymphocyte and increased monocyte count in peripheral blood is associated with cardiovascular disease and one- year mortality in maintenance hemodialysis patients
原文传递
导出
摘要 目的探讨血液透析(血透)患者外周血白细胞计数及其分类与心血管事件(CVD)发生及一年预后的关系。方法收集2009年3月至2011年3月期间在复旦大学上海医学院附属中山医院接受血液透析治疗的终末期肾病患者临床及血清学资料,并进行12个月的随访。采用Spearman相关和线性回归方法分析外周血白细胞及其分类与其他临床及实验室指标的相关关系。用t检验比较连续变量在CVD事件发生组和无CVD事件发生组的差异,用卡方检验比较分类变量差异。Kaplan—Meier生存分析和Cox风险比例模型分析白细胞及其分类对一年病死率的预测作用。结果共371例血液透析患者入组。与无CVD事件发生组相比,CVD组患者淋巴细胞数显著降低[(1.17±0.38)比(1.34±0.51),P〈0.05],单核细胞数显著升高[(0.44±0.15)比(0.37±0.15),P〈0.01]。淋巴细胞数升高者病死率较低(P〈0.01),单核细胞数升高者病死率较高(P〈0.01),其预测价值高于高敏C反应蛋白。结论外周血白细胞计数与血液透析患者CVD的发生相关,淋巴细胞数降低和单核细胞数升高是血透患者1年病死率的独立危险因素。 Objective To investigate the association between peripheral white blood cell count including its subtypes and cardiovascular disease (CVD) incidence and one-year all-cause mortality in maintenance hemodialysis (MHD) patients. Methods A total of 371 MHD patients at Zhongshan Hospital, Fudan University between March 2009 and February, 2011 were enrolled. Demographic, hematological, nutritional and inflammatory markers were obtained. All patients were followed for one year to investigate the risks for CVD event and mortality. Spearman correlation and linear regression were used to assess the relationship between white blood cell count and other laboratory parameters. Difference in categorical factors between two groups were determined with Chi-square test, Difference in continuous values between two groups were assessed with t test. Kaplan- Meier analysis and Cox proportional hazards model were applied to assess one- year mortality predictors. Results Patients with CVD event had lower lymphocyte count level (1.17±0.38 vs 1.34±0.51, P〈0.05) and higher monocyte count level (0.44 ± 0.15 vs 0.37 ± 0.15, P〈0.01) than those without CVD event. Cox proportional hazard regression showed that an increased lymphocyte count was associated with reduced mortality risk, 95% CI: 0.136-0.719, P 〈 0.01) and that an increased monocyte count was associated with increased mortality risk, 95% CI: 2.657- 74.396, P〈0.01) after adjustment for hsCRP. Conclusion Decreased lymphocyte level and increased monocyte level are significantly related to CVD event and are independent predictors of increased one- year all- cause mortality risk in MHD patients.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第8期589-594,共6页 Chinese Journal of Nephrology
基金 上海市科委基金资助(11XD1401400)
关键词 血液透析 心血管疾病 淋巴细胞 单核细胞 病死率 Hemodialysis Cardiovascular disease Lymphocyte Monocyte Mortality
  • 相关文献

参考文献29

  • 1Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998, 32(5 Suppl 3): Sl12-Sl19.
  • 2Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end- stage renal disease compared with the general oooulation. Kidney Int, 2000. 58: 1758-1764.
  • 3汤颖,钟一红,龚邵敏,王一梅,吕文律,丁小强.终末期肾病血液透析患者感染死亡事件调查[J].中华肾脏病杂志,2011,27(6):406-410. 被引量:41
  • 4Kannel WB, Anderson K, Wilson PW. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA, 1992, 267: 1253-1256.
  • 5Lee CD, Folsom AR, Nieto FJ, et al. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. Am J Epidemiol, 2001, 154: 758-764.
  • 6Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol, 2001, 54: 316-322.
  • 7Grimm ILl, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all- cause mortality. JAMA, 1985, 254: 1932-1937.
  • 8Brown DW, Ford ES, Giles WH, et al. Associations between White Blood Cell Count and Risk for Cerebrovascular Disease Mortality: NHANES II Mortality Study, 1976 - 1992. Annals of Epidemiology, 2004, 14: 425-430.
  • 9Reddan DN, Klassen PS, Szczech LA, et al. White blood cells as a novel mortality predictor in haemodialysis patients. Nephrol Dial Transplant, 2003, 18: 1167-1173.
  • 10Kato A, Takita T, Furuhashi M, et al. Blood monocyte count is a predictor of total and cardiovascular mortality in hemodialysis patients. Nephron Clin Pract, 2008, 110: c235- c243.

二级参考文献14

  • 1张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 2吕玉凤,刘必成.透析患者心血管疾病危险因素的逆流行病学现象[J].中华肾脏病杂志,2006,22(3):183-186. 被引量:14
  • 3彭建华,杨波,潘健涛.尿毒症血液透析患者肺部感染病原菌特点及药敏分析[J].医学临床研究,2007,24(4):647-649. 被引量:6
  • 4黄文坛,李家燕,龚智峰,闭闵,唐盛,曾西.维持性血液透析患者感染分布及危险因素探讨[J].中国感染控制杂志,2007,6(3):166-168. 被引量:11
  • 5丁强,钱家麒.血液净化疗法.∥王吉耀,主编.内科学.北京:人民卫生出版社,2006:664-677.
  • 6United States Renal Data System.Annual data report 2009.http://www.usrds.org/2009/pdf/V2_02_INC_PREV_09.PDF.
  • 7Foley RN,Guo H,Snyder JJ,et al.Septicemia in the United States Dialysis Population,1991 to 1999.J Am Soc Nephrol,2004,15:1038-1045.
  • 8Knerr K,Futh R,Hemsen P,et al.Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients.Cytokine,2005,30:132-138.
  • 9Collins AJ,Foley RN,Gilbertson DT,et al.The state of chronic kidney disease,ESRD,and morbidity and mortality in the first year of dialysis.Clin J Am Soc Nephrol,2009,4 Suppt 1:S5-S11.
  • 10Tsakiris D,Jones EHP,Briggs D,et al.Death within 90 days from starting renal replacement therapy in the ERAEDTA Resgistry between 1990 and 1992.Nephrol Dial Transplant,1999,14:2343-2350.

共引文献40

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部